[{"indications": "Indications\u00a0see under Dose and preparations", "name": "VERAPAMIL HYDROCHLORIDE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "2 Cardiovascular system", "2.6 Nitrates, calcium-channel blockers, and other antianginal drugs", "2.6.2 Calcium-channel blockers", "VERAPAMIL HYDROCHLORIDE"], "cautions": "Cautions\u00a0first-degree AV block; acute phase of myocardial infarction (avoid if bradycardia, hypotension, left ventricular\r\nfailure); patients taking beta-blockers (important: see below); interactions: Appendix 1 (calcium-channel blockers)Verapamil and beta-blockers\u00a0Verapamil injection should not be given to patients recently treated with\r\nbeta-blockers because of the risk of hypotension and asystole. The\r\nsuggestion that when verapamil injection has been given first, an\r\ninterval of 30 minutes before giving a beta-blocker is sufficient\r\nhas not been confirmed.It may also be hazardous to give verapamil and a beta-blocker\r\ntogether by mouth (should only be contemplated if myocardial function\r\nwell preserved).", "side-effects": "Side-effects\u00a0constipation; less commonly nausea, vomiting,\r\nflushing, headache, dizziness, fatigue, ankle oedema; rarely allergic\r\nreactions (erythema, pruritus, urticaria, angioedema, Stevens-Johnson\r\nsyndrome); myalgia, arthralgia, paraesthesia, erythromelalgia; increased\r\nprolactin concentration; rarely gynaecomastia and gingival hyperplasia\r\nafter long-term treatment; after intravenous administration or high\r\ndoses, hypotension, heart failure, bradycardia, heart block, and asystole; overdosage, see Emergency Treatment of Poisoning", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/2703.htm", "doses": ["By mouth, supraventricular arrhythmias\r\n(but see also Contra-indications), 40\u2013120\u00a0mg 3 times daily", "Angina, 80\u2013120\u00a0mg 3 times daily", "Hypertension, 240\u2013480\u00a0mg daily in 2\u20133 divided doses", "Prophylaxis of cluster headache [unlicensed] (under specialist\r\nsupervision), 240\u2013960\u00a0mg daily in 3\u20134 divided doses", "By slow intravenous injection over\r\n2 minutes (3 minutes in elderly), supraventricular arrhythmias (but\r\nsee also Contra-indications), 5\u201310\u00a0mg (preferably with ECG monitoring);\r\nin paroxysmal tachyarrhythmias a further 5\u00a0mg after 5\u201310 minutes if\r\nrequired"], "pregnancy": "Pregnancy\u00a0may reduce uterine blood flow with fetal hypoxia;\r\nmanufacturer advises avoid in first trimester unless absolutely necessary;\r\nmay inhibit labour"}, {"indications": "Indications\u00a0see under Dose and preparations", "name": "VERAPAMIL HYDROCHLORIDE Modified release", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "2 Cardiovascular system", "2.6 Nitrates, calcium-channel blockers, and other antianginal drugs", "2.6.2 Calcium-channel blockers", "VERAPAMIL HYDROCHLORIDE", "Modified release"], "cautions": "Cautions\u00a0first-degree AV block; acute phase of myocardial infarction (avoid if bradycardia, hypotension, left ventricular\r\nfailure); patients taking beta-blockers (important: see below); interactions: Appendix 1 (calcium-channel blockers)Verapamil and beta-blockers\u00a0Verapamil injection should not be given to patients recently treated with\r\nbeta-blockers because of the risk of hypotension and asystole. The\r\nsuggestion that when verapamil injection has been given first, an\r\ninterval of 30 minutes before giving a beta-blocker is sufficient\r\nhas not been confirmed.It may also be hazardous to give verapamil and a beta-blocker\r\ntogether by mouth (should only be contemplated if myocardial function\r\nwell preserved).", "side-effects": "Side-effects\u00a0constipation; less commonly nausea, vomiting,\r\nflushing, headache, dizziness, fatigue, ankle oedema; rarely allergic\r\nreactions (erythema, pruritus, urticaria, angioedema, Stevens-Johnson\r\nsyndrome); myalgia, arthralgia, paraesthesia, erythromelalgia; increased\r\nprolactin concentration; rarely gynaecomastia and gingival hyperplasia\r\nafter long-term treatment; after intravenous administration or high\r\ndoses, hypotension, heart failure, bradycardia, heart block, and asystole; overdosage, see Emergency Treatment of Poisoning", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/2705.htm", "doses": ["By mouth, supraventricular arrhythmias\r\n(but see also Contra-indications), 40\u2013120\u00a0mg 3 times daily", "Angina, 80\u2013120\u00a0mg 3 times daily", "Hypertension, 240\u2013480\u00a0mg daily in 2\u20133 divided doses", "Prophylaxis of cluster headache [unlicensed] (under specialist\r\nsupervision), 240\u2013960\u00a0mg daily in 3\u20134 divided doses", "By slow intravenous injection over\r\n2 minutes (3 minutes in elderly), supraventricular arrhythmias (but\r\nsee also Contra-indications), 5\u201310\u00a0mg (preferably with ECG monitoring);\r\nin paroxysmal tachyarrhythmias a further 5\u00a0mg after 5\u201310 minutes if\r\nrequired", "Name[Half Securon SR\u00ae (Abbott) ] Tablets, m/r, f/c, verapamil hydrochloride\r\n120\u00a0mg, net price 28-tab pack = \u00a37.71. \r\n    Label:\r\n    25Dose\u00a0 see Securon SR\u00ae"], "pregnancy": "Pregnancy\u00a0may reduce uterine blood flow with fetal hypoxia;\r\nmanufacturer advises avoid in first trimester unless absolutely necessary;\r\nmay inhibit labour"}]